Search Results - "Oskarsson, Jon Thorir"
-
1
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening
Published in Nature medicine (01-12-2023)Get full text
Journal Article -
2
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
Published in Haematologica (Roma) (2024)“…There is some evidence that a prior cancer is a risk factor for the development of multiple myeloma (MM). If this is true, prior cancer should be associated…”
Get full text
Journal Article -
3
-
4
-
5
P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION‐BASED STUDY IN ICELAND AND SWEDEN
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
6
Predicting an Underlying Clonal Plasma Cell Population in Light-Chain Monoclonal Gammopathy of Undetermined Significance Using Free Light-Chain Ratio
Published in Blood (02-11-2023)“…Introduction: The management of light-chain (LC) monoclonal gammopathy of undetermined significance (MGUS) presents inherent challenges as the key diagnostic…”
Get full text
Journal Article -
7
Risk Factors of Smoldering Multiple Myeloma: Results from the Screened Istopmm Study
Published in Blood (02-11-2023)“…Introduction Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition to multiple myeloma (MM) that carries a higher risk of progression to MM…”
Get full text
Journal Article -
8
Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
Published in Blood (23-11-2021)“…Background Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition to multiple myeloma (MM). Emerging data from clinical trials indicate that…”
Get full text
Journal Article -
9
Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
Published in Blood (23-11-2021)“…Background: Cancer screening is performed worldwide for several malignancies. Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple…”
Get full text
Journal Article -
10
Circulating Tumor Plasma Cells in the Screened Istopmm Smoldering Multiple Myeloma Cohort
Published in Blood (15-11-2022)Get full text
Journal Article -
11
-
12
Monoclonal Gammopathy of Undetermined Significance (MGUS) with Multiple Paraproteins: Results from the Population-Based Istopmm Screening Study
Published in Blood (15-11-2022)Get full text
Journal Article -
13
Transient M-Proteins: Epidemiology, Causes, and the Impact of Mass Spectrometry: The Istopmm Study
Published in Blood (15-11-2022)Get full text
Journal Article -
14
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study
Published in Blood cancer journal (New York) (11-12-2023)“…Monoclonal gammopathy of undetermined significance (MGUS) is the earliest discernible stage of multiple myeloma (MM) and Waldenström’s macroglobulinemia (WM)…”
Get full text
Journal Article -
15
Prevalence of smoldering multiple myeloma based on nationwide screening
Published in Nature medicine (01-02-2023)“…Smoldering multiple myeloma (SMM) is an asymptomatic precursor to multiple myeloma. Here we define the epidemiological characteristics of SMM in the general…”
Get full text
Journal Article -
16
-
17
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Published in Blood cancer journal (New York) (17-05-2021)“…Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma (MM). Population-based screening for MGUS could identify candidates for…”
Get full text
Journal Article -
18
Monitoring of Circulating Tumor Plasma Cells in Patients with Precursor Conditions of Multiple Myeloma: Data from the Prospective Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
Published in Blood (23-11-2021)“…Background: A proportion of patient with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) will progress to…”
Get full text
Journal Article -
19
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis
Published in Cytometry. Part B, Clinical cytometry (01-03-2022)“…Background Multiple myeloma (MM) measurable residual disease (MRD) evaluated by flow cytometry is a surrogate for progression‐free and overall survival in…”
Get full text
Journal Article -
20